The trademark application DEVELOPING SCIENCE, DELIVERING THERAPIES was filed by 4D Pharma PLC, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). Application refused.
The application was filed in English (German was selected as the second language).
The Appeal with reference B R0698/2022-4 was Application rejected according to Article 7(1)(b) EUTMR with decision issued on September 11, 2022 by the EUIPO. The Refusal with reference B 018466250 was Rejected according to Article 7(1)(b) EUTMR with decision issued on March 1, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceuticals as live biotherapeutics
Live biotherapeutics for the treatment of inflammatory and autoimmune diseases
Live biotherapeutics for the treatment of cancer
Live biotherapeutics for the treatment of gastrointestinal diseases
Live biotherapeutics for the treatment of central nervous system diseases
Live biotherapeutic bacterial formulations for medical use
Preparations of microorganisms for medical use.
The mark was filed in class 42 with following description of goods:
Scientific research and development
Pharmaceutical research and development
Microbiology research and development into live biotherapeutics.